Industry Overview

North America mammography market was valued at $1,466.5 million in 2025 and is projected to reach $3,992.7 million by 2035, growing at a CAGR of 10.6% during the forecast period (2026–2035). The North American mammography sector has witnessed significant advancements in recent years. Increasing awareness about early detection of breast cancer has encouraged broader adoption of screening programs. Manufacturers are introducing innovative imaging technologies that enhance diagnostic precision. Collaborative initiatives between healthcare providers and technology companies are facilitating better access to mammography services. For instance, Hologic Inc. has expanded its portfolio with advanced 3D mammography systems. These developments collectively contribute to sustained market growth in the region.

Market Dynamics

Rise of 3D Mammography Systems

The adoption of three-dimensional mammography is reshaping the screening landscape. Enhanced imaging capabilities allow for improved detection rates, particularly in dense breast tissues. Leading companies, such as GE Healthcare, are introducing next-generation tomosynthesis solutions to hospitals and diagnostic centers. These innovations reduce false positives and improve patient outcomes. The trend underscores a shift toward precision-focused imaging technologies. It continues to drive investments in both urban and rural healthcare facilities.

Integration of AI in Diagnostic Workflows

Artificial intelligence is increasingly being incorporated into mammography analysis. AI algorithms assist radiologists in identifying anomalies with higher accuracy and speed. Siemens Healthineers, for example, has launched AI-enabled mammography platforms that streamline diagnostic workflows. The technology supports proactive decision-making and reduces human error. Growing reliance on AI is shaping both clinical protocols and equipment design. This integration signals a broader move toward intelligent, data-driven healthcare solutions.

Market Segmentation

• Based on the product type, the market is segmented into digital systems, analog systems, biopsy systems, film screen systems, and others.
• Based on the application, the market is segmented into hospitals & clinics and diagnostic centers.

Digital Systems Segment to Lead the Market with the Largest Share

Digital mammography has become a cornerstone of breast imaging in North America. Advanced digital detectors provide clearer images while lowering radiation exposure. Companies like Carestream Health have introduced high-resolution digital mammography systems tailored for hospital and clinic environments. These systems offer improved image storage, retrieval, and sharing capabilities. The increasing preference for digital over analog systems is evident in clinical adoption patterns. As a result, digital solutions are driving both technological and commercial growth in the market.

Hospitals & Clinics: A Key Segment in Market Growth

Hospitals and specialized clinics remain pivotal in expanding mammography services. Investments in diagnostic infrastructure and patient-centric care models are enhancing accessibility. For example, Fujifilm’s mammography units have been deployed across numerous hospitals in North America, supporting both routine screening and high-risk patient monitoring. The presence of these units in large healthcare networks facilitates wider coverage. Partnerships between equipment providers and healthcare institutions further promote technological adoption. Consequently, hospitals and clinics play a critical role in the market’s expansion.

Regional Outlook

North America Mammography market is further divided by countries, including the US and Canada.

US Dominates the Market with Major Share

The US mammography sector continues to grow due to heightened focus on early detection programs. Advanced imaging technologies, such as 3D and AI-enabled mammography, are increasingly utilized in clinical settings. Hologic Inc. has been instrumental in offering innovative mammography solutions tailored to US healthcare facilities. Regulatory support and reimbursement policies encourage regular screenings, particularly among women over 40. Integration of modern equipment into outpatient centers and hospitals is improving patient throughput. Together, these factors are fostering steady growth within the US market.

Market Players Outlook

The major companies operating in the North America mammography market include Canon Medical Systems USA, Inc., Carestream Health, Inc., GE HealthCare Technologies, Inc., Hologic, Inc., and iCAD, Inc., among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.

Recent Developments

• In September 2025, Hologic Inc., widely recognized for digital mammography and 3D tomosynthesis technologies, Hologic's AI-powered Genius AI Detection 2.0 has received FDA approval and continues to support aggressive screening initiatives.

• In April 2025, GE HealthCare launched Pristina Via, an upgrade to its Senographe Pristina mammography system, featuring advanced workflow tools and SmartMammo AI developed in partnership with RadNet’s DeepHealth. These solutions are being deployed in settings such as malls and Walmart locations, broadening access.

• In January 2025, Siemens introduced the Mammomat B.brilliant platform at GRACE Breast Imaging in Iowa, its first US installation, and secured FDA approval for advanced 3D image acquisition and reconstruction.

The Report Covers

• Market value data analysis of 2025 and forecast to 2035.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the North America mammography market. Based on the availability of data, information related to new products and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.